ANGELA MACERI: Open Payments
NPI 1679010821 · TROY, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$910 in 48 payments from 19 companies in 2025. Trend: 2023 $778 · 2024 $980 · 2025 $910
Food & beverage: $910
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 6 | $110 |
| GlaxoSmithKline, LLC. | 6 | $105 |
| AstraZeneca Pharmaceuticals LP | 6 | $102 |
| ABBVIE INC. | 4 | $98 |
| PFIZER INC. | 5 | $81 |
| Janssen Pharmaceuticals, Inc | 2 | $59 |
| Exact Sciences Corporation | 3 | $57 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $38 |
| Axsome Therapeutics, Inc. | 2 | $37 |
| JAZZ PHARMACEUTICALS INC. | 2 | $37 |
Products named: Ozempic, TRELEGY ELLIPTA, NURTEC ODT, SPRAVATO, Cologuard Collection Kit, BREZTRI, VRAYLAR, XIFAXAN.
Industry payments across MI — which companies pay providers there.
